FI962813A - IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen - Google Patents

IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen Download PDF

Info

Publication number
FI962813A
FI962813A FI962813A FI962813A FI962813A FI 962813 A FI962813 A FI 962813A FI 962813 A FI962813 A FI 962813A FI 962813 A FI962813 A FI 962813A FI 962813 A FI962813 A FI 962813A
Authority
FI
Finland
Prior art keywords
stimulate
peripheral blood
mononuclear cells
blood mononuclear
cytolytic activity
Prior art date
Application number
FI962813A
Other languages
English (en)
Swedish (sv)
Other versions
FI962813A0 (fi
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962813A publication Critical patent/FI962813A/fi
Publication of FI962813A0 publication Critical patent/FI962813A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FI962813A 1994-01-20 1996-07-11 IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen FI962813A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (zh) 1994-01-20 1994-01-20 用白介素-10激活外周血单核细胞的细胞溶解活性
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
FI962813A true FI962813A (fi) 1996-07-11
FI962813A0 FI962813A0 (fi) 1996-07-11

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962813A FI962813A0 (fi) 1994-01-20 1996-07-11 IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen

Country Status (10)

Country Link
EP (1) EP0740552A1 (fi)
JP (1) JPH09508116A (fi)
CN (1) CN1142186A (fi)
AU (1) AU707019B2 (fi)
FI (1) FI962813A0 (fi)
NO (1) NO963029L (fi)
NZ (1) NZ259584A (fi)
PL (1) PL175343B1 (fi)
SK (1) SK91696A3 (fi)
WO (1) WO1995019780A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
EP2295450B1 (en) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegylated interleukin-10
RU2322452C2 (ru) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Иммуномодулирующая композиция
WO2008054585A2 (en) * 2006-09-28 2008-05-08 Schering Corporation Use of pegylated il-10 to treat cancer
WO2009003185A1 (en) * 2007-06-27 2008-12-31 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
EP2379115B1 (en) 2008-12-17 2017-10-25 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０を疾病及び疾患の治療に用いる方法
AU2014281828B2 (en) 2013-06-17 2019-05-09 Armo Biosciences, Inc. Method for assessing protein identity and stability
JP6509867B2 (ja) 2013-08-30 2019-05-08 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためにインターロイキン−１０を使用する方法
CA2928710A1 (en) 2013-11-11 2015-05-14 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP2017536098A (ja) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１５組成物及びその使用
CN107106655A (zh) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 使用白细胞介素‑10治疗疾病和病症的方法
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016191587A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
CN108025040A (zh) 2015-08-25 2018-05-11 阿尔莫生物科技股份有限公司 使用白介素-10治疗疾病和病症的方法
WO2023072870A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218598B (hu) * 1991-01-16 2000-10-28 Schering Corp. Eljárás interleukin-10-et tartalmazó, tumorok kezelésére szolgáló gyógyszerkészítmények előállítására
EP0495639A1 (en) * 1991-01-16 1992-07-22 Schering Corporation Use of interleukin-10 in adoptive immunotherapy of cancer
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
NZ259584A (en) 1998-01-26
JPH09508116A (ja) 1997-08-19
NO963029D0 (no) 1996-07-19
NO963029L (no) 1996-09-19
CN1142186A (zh) 1997-02-05
PL315513A1 (en) 1996-11-12
SK91696A3 (en) 1997-04-09
WO1995019780A1 (en) 1995-07-27
AU707019B2 (en) 1999-07-01
PL175343B1 (pl) 1998-12-31
FI962813A0 (fi) 1996-07-11
EP0740552A1 (en) 1996-11-06
AU5842594A (en) 1995-08-08

Similar Documents

Publication Publication Date Title
FI962813A (fi) IL-10:n käyttö perifeerisen veren yksitumaisten solujen sytolyyttisen aktiivisuuden stimuloimiseen
DE69510836D1 (de) An den Körper anschmiegender absorbierender Artikel
FI963482A0 (fi) Menetelmä hematopoieesin stimuloimiseksi hemoglobiinilla
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
PL330862A1 (en) Clinical application of proteinous kinase c in order to increase clinical effectiveness of anticarcinogenic pharmaco- and radiotherapy
FI990171A (fi) Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi
TR23668A (tr) Insan gövdesi akintisinin toplanmasi
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
DE3786714D1 (de) Therapeutisches mittel fuer hautgeschwuere.
PT86144A (en) Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith
DK489587D0 (da) Medicinsk hudpraeparat
NO844462L (no) Bruk av ultraren hyaluronsyre for aa forbedre dyreleddfunksjoner
ZA94212B (en) Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
GB9704807D0 (en) Gel for application to the human or animal body
GB2189144B (en) Zinc complex of 5-chloro-7-iodo-8hydroxyquinoline having antimycotic activity and therapeutic use thereof.
DE69825949D1 (de) Programmierbarer Herzschrittmacher zur Stimulation mehrerer Herzbereiche
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
AU8799398A (en) Physiological combination of active substances to enhance the skin's defenses against noxious agents
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
IT8719420A0 (it) Purificazione di interleuchina-1umana ricombinante.
GB2172704B (en) Antigenically active protein and its use in the diagnosis of gonorrhoea
FI950951A (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
DK210187A (da) Medicinsk tampon